About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials | 6,381 Studies Recruiting

Clinical TrialsColorectal Cancer

Colorectal Cancer Clinical Trials

Browse 6,381 clinical trials for colorectal cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1001-1020 of 6,381 trials

TerminatedEffects of S-1 and Capecitabine on Coronary Artery Blood FlowFluoropyrimidine chemotherapy agents , such as 5-fluorouracil and capecitabine, are occasionally associated with cardiac toxicity.NCT02216149·Helsinki CompletedEvaluation of Ocoxin®-Viusid® in Metastatic Colorectal AdenocarcinomaThe research product, registered as a nutritional supplement (Ocoxin®, oral solution), manufactured by Laboratorios Catalysis S.NCT03559543·Havana UnknownBevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00797485·Naples

Related Searches

colon cancertrials rectal cancertrials

Data from ClinicalTrials.govTerms

CompletedA Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRCThe purpose of this study to assess efficacy and tolerability of combination therapy FOLFOXIRI with Bevacizumab (BV) as a first-line therapy in patients with metastatic colorectal…NCT02246049·Shinjuku, Tokyo

RecruitingIntermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerThe investigators hypothesize that intermittent first-line Panitumumab plus FOLFIRI is effective in first line as the same regimen given continuously, resulting in a Time to…NCT06509126·Naples

RecruitingLiving Donor Liver Transplantation for Unresectable Colorectal Cancer Liver MetastasesPatients with unresectable liver metastases (LM) from colorectal cancer (CRC)have a poor prognosis. In patients with resectable disease, surgery offers a distinct survival benefit.NCT02864485·Toronto, Ontario

UnknownA Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaThis is a Phase 2, multicenter, multiple-arm, open-label study to evaluate the efficacy, safety, and tolerability of EZN-2208.NCT00931840·Tucson, Arizona and 59 others

UnknownPreop CPET Testing and Exercise Training in Colorectal PatientsColorectal Surgery Preoperative Exercise Training is a study being run by the colorectal surgery team at the Norfolk and Norwich University Hospital and the University of East…NCT01924897·Norwich, Norfolk and 1 other

RecruitingEffects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (PERMICA)Colorectal cancer is the third most common cancer worldwide, yet it was the second leading cause of cancer-related deaths in 2020.NCT06809660·Poitiers

TerminatedCediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerThis phase I trial is studying the side effects and best dose of cediranib maleate when given together with whole brain radiation therapy in treating patients with brain…NCT00937482·Boston, Massachusetts

UnknownComparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With ThrombocytopeniaThis randomized controlled clinical phase II study was designed to compare the effect of rhTPO with rhIL-11 in improving thrombocytopenia in patients with recurrent colorectal…NCT03823079

CompletedNutritional Support in Patients Undergoing Surgical Treatment of Colorectal CancerAccording to available data, 30-60% of patients are undernourished at hospital admission. The significance of the perioperative nutrition has already been studied in the 1930s.NCT03930888·Ostrava, Moravian-Silesian Region

UnknownRole of CD133 & Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant TreatmentMicrosatellite instability is more common in colorectal cancer ( CRC) young patient which is associated with good prognosis and is considered as a predictor for good response to…NCT03002727·Asyut

CompletedOutcomes of Colonoscopy With Non-anesthesiologist Administered PropofolThe Efficacy and safety of Non-anesthesiologist administered propofol (NAAP) for gastrointestinal endoscopy have been widely documented although there is not information which has…NCT03922074

CompletedCorrelating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal CancerThe purpose of this study is to assess whether in a population of patients with advanced colorectal cancer for which no known effective therapy is available, measuring the…NCT01591590·Brussels

CompletedThe Improving Cancer Aftercare Study.This is a qualitative interview study that aims to understand treatment burden in individuals who have experienced prostate or colorectal cancer treatment within the past five…NCT04163068·Aberdeen, UK

RecruitingSmart Pill for Measuring Gut Health in Colon Inflammation and Colon CancerThe goal of this observational pilot study with invasive measurements is to explore whether an ingestible sensor pill can be of use in diagnosis or monitoring of disease in…NCT07046468·Nijmegen, Gelderland

UnknownWeb-based Learning Module on Optical Diagnosis of Early Colorectal CancerInternational guidelines recommend deciding the treatment of colorectal lesions based on the estimated histology by endoscopic optical diagnosis.NCT05663788·Chapel Hill, North Carolina and 11 others

CompletedPeRioperative Omega Three and the Effect on ImmuNityBowel cancer is the second most common cause of cancer-related death in the UK, with 50,000 new cases and over 15,000 deaths annually.NCT03598413·Guildford, Surrey

RecruitingPatient Preference for Subcutaneous vs. Intravenous Immune TherapyThe study will evaluate patient and Health Care Professional- reported preference for Subcutaneous (SC) compared with IV nivolumab administration or similarly for SC compared with…NCT07223424·Pittsburgh, Pennsylvania

PreviousPage 51 of 320Next